298. Hereditary pancreatitis Clinical trials / Disease details


Clinical trials : 98 Drugs : 180 - (DrugBank : 57) / Drug target genes : 53 - Drug target pathways : 142

  
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT05270434
(ClinicalTrials.gov)
March 1, 202210/1/2022Optimal Timing of Endoscopic Intervention in the Treatment of Chronic Pancreatitis.Optimal Timing of Endoscopic Intervention After Extracorporeal Shock-Wave Lithotripsy in the Treatment of Chronic Pancreatitis With Pancreatic Stones.Pancreatitis, ChronicProcedure: time interval between ESWL and ERCP is 12h;Procedure: time interval between ESWL and ERCP is 12-36h;Procedure: time interval between ESWL and ERCP is greater than 36h;Drug: morphine, buprenorphine, pethidine, tramaldol, metamizole and acetylsalicylacid (Analgesics)Changhai HospitalNULLNot yet recruiting18 Years75 YearsAll225N/AChina